The conference emphasized that the current scientific and technological work of drug supervision is in a period of important strategic opportunity. It is necessary to unify ideas and actions into the decisions and deployment of the Party Central Committee, adhere to regulatory requirements and scientific and technological innovation support, integrate scientific and technological work into all aspects of review and approval, inspection and verification, monitoring and evaluation, adhere to the “four directions” to lead the direction of scientific and technological research, insist on the “four strictest” inspection of the effectiveness of scientific and technological work, and promote innovation through strong supervision and supervision.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.